首页> 美国政府科技报告 >Neoadjuvant Anti-Angiogenesis Therapy for Prostate Cancer
【24h】

Neoadjuvant Anti-Angiogenesis Therapy for Prostate Cancer

机译:新辅助抗血管生成治疗前列腺癌

获取原文

摘要

This proposed clincial trial targets men at risk for recurrence after prostatectomy by treating systemic micrometastatic disease in addition to local. Thus far, anti-angiogenesis therapy is safe in men undergoing radical prostatectomy and postulated changes in angiogenic factors as well as grade and stage have been observed.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号